Literature DB >> 7808506

The Eiken Latex test for detection of a cryptococcal antigen in cryptococcosis. Comparison with a monoclonal antibody-based latex agglutination test, Pastorex Cryptococcus.

K Tanaka1, S Kohno, T Miyazaki, H Miyazaki, K Mitsutake, S Maesaki, M Kaku, H Koga.   

Abstract

A latex agglutination test for cryptococcal antigen, the Eiken Latex test (Eiken, Tokyo, Japan), was compared with a monoclonal antibody-based agglutination assay, Pastorex Cryptococcus (Diagnostics Pasteur, Marneur-la-Coquette, France). In a murine model of disseminated cryptococcosis, the kinetics of the antigen titers by the Eiken Latex were similar to those by the Pastorex Cryptococcus, but sensitivity was much higher. In HIV-negative patients with pulmonary cryptococcosis, a cryptococcal antigen was detected in 6 of 10 patients by the Eiken Latex test and in only 3 of those patients by the Pastorex Cryptococcus. The results indicate that the Eiken Latex is more sensitive for the detection of the cryptococcal antigen, even in non-disseminated cryptococcosis. The sensitivity and specificity of the Eiken Latex were examined using 195 sera from 25 patients with pulmonary cryptococcosis and 170 patients with non-cryptococcosis. The cutoff value of > or = 1:8 showed a sensitivity of 76% (19/25) and a specificity of 98.9% (168/170).

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7808506     DOI: 10.1007/bf01102911

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  5 in total

1.  Evaluation of an enzyme immunoassay for detection of cryptococcal capsular polysaccharide antigen in serum and cerebrospinal fluid.

Authors:  U K Frank; S L Nishimura; N C Li; K Sugai; D M Yajko; W K Hadley; V L Ng
Journal:  J Clin Microbiol       Date:  1993-01       Impact factor: 5.948

2.  Liposome-encapsulated amphotericin B in the treatment of experimental murine candidiasis.

Authors:  T Miyazaki; S Kohno; M Kaku; H Koga; K Yamaguchi
Journal:  Tohoku J Exp Med       Date:  1990-08       Impact factor: 1.848

3.  Production, characterization, and antibody specificity of a mouse monoclonal antibody reactive with Cryptococcus neoformans capsular polysaccharide.

Authors:  F Dromer; J Salamero; A Contrepois; C Carbon; P Yeni
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

4.  Evaluation of a monoclonal antibody-based latex agglutination test for diagnosis of cryptococcosis: comparison with two tests using polyclonal antibodies.

Authors:  A Temstet; P Roux; J L Poirot; O Ronin; F Dromer
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

5.  High detection rates of cryptococcal antigen in pulmonary cryptococcosis by Eiken latex agglutination test with pronase pretreatment.

Authors:  S Kohno; A Yasuoka; H Koga; M Kaku; S Maesaki; K Tanaka; K Mitsutake; H Matsuda; K Hara
Journal:  Mycopathologia       Date:  1993-08       Impact factor: 2.574

  5 in total
  4 in total

1.  Cryptococcosis in AIDS.

Authors:  P Imwidthaya; N Poungvarin
Journal:  Postgrad Med J       Date:  2000-02       Impact factor: 2.401

2.  Detection of Cryptococcus neoformans gene in patients with pulmonary cryptococcosis.

Authors:  K Tanaka; T Miyazaki; S Maesaki; K Mitsutake; H Kakeya; Y Yamamoto; K Yanagihara; M A Hossain; T Tashiro; S Kohno
Journal:  J Clin Microbiol       Date:  1996-11       Impact factor: 5.948

3.  Plasma (1-->3)-beta-D-glucan and fungal antigenemia in patients with candidemia, aspergillosis, and cryptococcosis.

Authors:  T Miyazaki; S Kohno; K Mitsutake; S Maesaki; K Tanaka; N Ishikawa; K Hara
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

4.  Immunodiagnosis of paracoccidioidomycosis due to Paracoccidioides brasiliensis using a latex test: detection of specific antibody anti-gp43 and specific antigen gp43.

Authors:  Priscila Oliveira Dos Santos; Anderson Messias Rodrigues; Geisa Ferreira Fernandes; Silvia Helena Marques da Silva; Eva Burger; Zoilo Pires de Camargo
Journal:  PLoS Negl Trop Dis       Date:  2015-02-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.